Early detection of cancer – why is it important?

The number of people diagnosed with tumors, especially malignant ones, is constantly increasing. There is also a rise in mortality rate due to delayed diagnosis and inappropriate treatment. Therefore, proper cancer diagnosis is very important. Early detection of a tumor makes it more probable that the patient will, finally, beat the cancer and recover. However, [...]

By |2019-03-21T09:37:56+00:00July 6th, 2017|Chronix news|0 Comments

Chronix Biomedical reports positive interim pancreatic cancer data

Chronix Biomedical reports a positive interim analysis of its ongoing validation study of its Copy Number Instability (CNI)-based therapeutic monitoring test in pancreatic cancer. The study compares the accuracy of Chronix’s CNI-based test at predicting a clinical response, as early as after the first cycle of chemotherapy compared to CA19-9, a commonly used biomarker.

By |2019-03-21T09:37:57+00:00June 14th, 2017|Chronix news|0 Comments